![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
1 Am J Clin Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation
Practices for Node-negative Intact Breast Cancer.
Am J Clin Oncol. 2025 Feb 4. doi: 10.1097/COC.0000000000001167.
PubMed
Abstract available
Whole genome sequencing powered ctDNA sequencing for breast cancer detection.
Ann Oncol. 2025 Feb 4:S0923-7534(25)00053-5. doi: 10.1016/j.annonc.2025.
PubMed
Abstract available
The American Joint Committee on Cancer (AJCC) Breast Cancer Staging, Eighth
Edition, is more Reflective of Cancer Biology than the Seventh Edition.
Ann Surg Oncol. 2025 Feb 7. doi: 10.1245/s10434-025-16889.
PubMed
Abstract available
ASO Author Reflections: Personal Insights and Reflections on the Burden of Breast
Cancer Among Adolescents and Young Adults.
Ann Surg Oncol. 2025 Feb 6. doi: 10.1245/s10434-024-16858.
PubMed
ASO Visual Abstract: Risk of Surgical Overtreatment in cN1 Breast Cancer Patients
Who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.
Ann Surg Oncol. 2025 Feb 3. doi: 10.1245/s10434-025-16952.
PubMed
Protective Factors Associated with Normal Lymphatic Function After Axillary Lymph
Node Dissection for Breast Cancer Treatment.
Ann Surg Oncol. 2025 Feb 3. doi: 10.1245/s10434-025-16918.
PubMed
Abstract available
Correlation of HLA-A and HLA-B/C Expression With ESR1 Expression in Patients With
Metastatic Breast Cancer as a Potential Prognosticator of Favorable Distant
Disease-free Survival.
Anticancer Res. 2025;45:445-450.
PubMed
Abstract available
Clinical Utility of Sentinel Lymph Node Biopsy Using the Medical Imaging
Projection System in Breast Cancer Patients, Including Those Following
Neoadjuvant Chemotherapy.
Anticancer Res. 2025;45:789-796.
PubMed
Abstract available
Noncancerous Exosomes Establish a Growth Promoting Paracrine Effect on Triple
Negative Breast Cancer Cells.
Anticancer Res. 2025;45:419-431.
PubMed
Abstract available
Recombinant Methioninase (rMETase) Synergistically Sensitizes
Ivermectin-resistant MCF-7 Breast Cancer Cells 9.9 Fold to Low-dose Ivermectin.
Anticancer Res. 2025;45:451-455.
PubMed
Abstract available
MiR-5586-5p Suppresses Hypoxia-induced Angiogenesis Through Multiple Targeting of
HIF-1alpha, HBEGF and ADAM17 in Breast Cancer.
Anticancer Res. 2025;45:473-489.
PubMed
Abstract available
A comparative study of mitoxantrone hydrochloride injection and technetium-99 m
for tracing axillary sentinel nodes in patients with breast cancer.
BMC Cancer. 2025;25:209.
PubMed
Abstract available
Breast cancer risk assessment based on a predictive model: evaluation of risk
factors among Japanese women.
BMC Cancer. 2025;25:206.
PubMed
Abstract available
What does intimate partner violence mean for women with breast cancer?
Experiences of Iranian women.
BMC Cancer. 2025;25:190.
PubMed
Abstract available
Women's perspectives of molecular breast imaging: a qualitative study.
Br J Cancer. 2025;132:276-282.
PubMed
Abstract available
Importance of circulating tumor DNA analysis at diagnosis in early
triple-negative breast cancer patients.
Breast Cancer. 2025 Jan 31. doi: 10.1007/s12282-025-01673.
PubMed
Abstract available
The impact of breast surgery and systemic therapy on the survival of patients
with de novo stage IV breast cancer.
Breast Cancer. 2025 Feb 2. doi: 10.1007/s12282-025-01675.
PubMed
Abstract available
Breast cancer statistics for Japan in 2022: annual report of the national
clinical database-breast cancer registry-clinical implications including
chemosensitivity of breast cancer with low estrogen receptor expression.
Breast Cancer. 2025 Feb 6. doi: 10.1007/s12282-025-01671.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
Predicting Axillary Lymph Node Metastasis in Young Onset Breast Cancer: A
Clinical-Radiomics Nomogram Based on DCE-MRI.
Breast Cancer (Dove Med Press). 2025;17:103-113.
PubMed
Abstract available
Exploring the role of ESR1 mutations in metastatic hormone receptor-positive
breast cancer T cell immune surveillance disruption.
Breast Cancer Res. 2025;27:19.
PubMed
Abstract available
Quantifying the tumour vasculature environment from CD-31 immunohistochemistry
images of breast cancer using deep learning based semantic segmentation.
Breast Cancer Res. 2025;27:17.
PubMed
Abstract available
Metabolites and lipid species mediate the associations of adiposity in childhood
and early adulthood with mammographic breast density in premenopausal women.
Breast Cancer Res. 2025;27:18.
PubMed
Abstract available
Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with
metastatic breast cancer.
Breast Cancer Res. 2025;27:16.
PubMed
Abstract available
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early breast
cancer: a discrete choice survey study.
Breast Cancer Res Treat. 2025 Feb 7. doi: 10.1007/s10549-025-07627.
PubMed
Abstract available
CD68 positive and/or CD163 positive tumor-associated macrophages and PD-L1
expression in breast phyllodes tumor.
Breast Cancer Res Treat. 2025;209:261-273.
PubMed
Abstract available
Germline genetic mutations in a multi-center cohort of 248 phyllodes tumors.
Breast Cancer Res Treat. 2025;209:275-282.
PubMed
Abstract available
Discordance between peritumoral and subareolar injections for mapping sentinel
lymph nodes in the breast.
Breast Cancer Res Treat. 2025;209:283-290.
PubMed
Abstract available
Magnetic lymphatic tracing for omission of sentinel lymph node biopsies in
mastectomy patients: a community cancer center experience.
Breast Cancer Res Treat. 2025;209:161-166.
PubMed
Abstract available
Frequency and outcomes of new or suspicious MRI findings on breast MRI for
patients on neoadjuvant therapy.
Breast Cancer Res Treat. 2025;209:521-531.
PubMed
Abstract available
The association between cirrhosis and outcomes among female patients undergoing
surgery for breast cancer in Ontario: a population-based study.
Breast Cancer Res Treat. 2025 Feb 3. doi: 10.1007/s10549-025-07612.
PubMed
Abstract available
Gene expression profiling tests to guide adjuvant chemotherapy decisions in lymph
node-positive early breast cancer: a systematic review.
Breast Cancer Res Treat. 2025 Feb 3. doi: 10.1007/s10549-024-07596.
PubMed
Abstract available
Patient-reported outcomes after immediate and delayed DIEP-flap breast
reconstruction in the setting of post-mastectomy radiation therapy-results of the
multicenter UMBRELLA breast cancer cohort.
Breast Cancer Res Treat. 2025 Feb 3. doi: 10.1007/s10549-025-07613.
PubMed
Abstract available
Pathologic complete response rates of patients with ER-low/HER2-negative breast
cancer treated with neoadjuvant pembrolizumab plus chemotherapy in the neo-real
study.
Breast Cancer Res Treat. 2025 Feb 3. doi: 10.1007/s10549-025-07628.
PubMed
Abstract available
Returning to work after breast cancer: a longitudinal analysis of employment and
financial hardship.
Breast Cancer Res Treat. 2025 Feb 2. doi: 10.1007/s10549-025-07624.
PubMed
Abstract available
Molecular Dynamics of Breast Cancer Subtypes: The Role of FAM83H-AS1 Long
Non-coding RNA in Breast Cancer Metastasis.
Breast Cancer Res Treat. 2025 Feb 1. doi: 10.1007/s10549-024-07603.
PubMed
Abstract available
Diet quality and cardiometabolic health in breast cancer survivors: the Pathways
Study.
Breast Cancer Res Treat. 2025 Feb 1. doi: 10.1007/s10549-025-07629.
PubMed
Abstract available
Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after
neoadjuvant systemic therapy: systematic review and meta-analysis.
Breast Cancer Res Treat. 2025;209:229-252.
PubMed
Abstract available
The association of distress and depression screening measures and other
electronic health record information with adjuvant endocrine therapy persistence.
Breast Cancer Res Treat. 2025;209:541-552.
PubMed
Abstract available
Malignancy risk stratification prediction of BI-RADS 4B calcifications based on
contrast-enhanced mammographic features: a multicenter study.
Breast Cancer Res Treat. 2025;210:135-145.
PubMed
Abstract available
Effects on lymph node size, staging and primary tumor histology on diagnostic
accuracy of axillary lymph node aspirate of breast cancers.
Breast Cancer Res Treat. 2025;209:15-20.
PubMed
Abstract available
Performance of high-resolution diffusion-weighted magnetic resonance imaging for
detecting clinically occult early breast cancers: a multi-reader study.
Breast Cancer Res Treat. 2025;210:71-86.
PubMed
Abstract available
Current status and challenges in HER2 IHC assessment: scoring survey results in
Japan.
Breast Cancer Res Treat. 2025;210:27-36.
PubMed
Abstract available
Disease recurrence in patients undergoing mastectomy for ductal carcinoma in
situ.
Breast Cancer Res Treat. 2025;209:675-679.
PubMed
Abstract available
Community-engaged adaptation of ACCESS: A navigator-led early palliative care
intervention for Black and Latina women with advanced breast cancer.
Cancer. 2025;131:e35745.
PubMed
Abstract available
Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade
combinations in triple-negative breast cancer.
Cancer Cell. 2025 Jan 30:S1535-6108(25)00025-X. doi: 10.1016/j.ccell.2025.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Unraveling the Impact of Drug Metabolism on Tamoxifen Response in Breast Cancer.
Cancer Epidemiol Biomarkers Prev. 2025;34:221-223.
PubMed
Abstract available
Dual targeting PPARalpha and NPC1L1 metabolic vulnerabilities blocks tumorigenesis.
Cancer Lett. 2025;612:217493.
PubMed
Abstract available
Targeting dormant disseminated tumor cells and their permissive niche by
pro-resolving mediators derived from resolution-phase macrophages.
Cancer Lett. 2025;612:217468.
PubMed
Abstract available
Ribosomal RNA Biosynthesis Functionally Programs Tumor-Associated Macrophages to
Support Breast Cancer Progression.
Cancer Res. 2025 Feb 4. doi: 10.1158/0008-5472.CAN-24-0707.
PubMed
Abstract available
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast
Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1
Inhibition.
Cancer Res. 2025;85:551-566.
PubMed
Abstract available
In Search of Representative Translational Cancer Model Systems.
Cancer Res. 2025;85:407-409.
PubMed
Abstract available
High-resolution spatially resolved proteomics of complex tissues based on
microfluidics and transfer learning.
Cell. 2025;188:734-748.
PubMed
Abstract available
Health Information on Breast Cancer Surgery on YouTube(R).
Clin Breast Cancer. 2025 Jan 15:S1526-8209(25)00013.
PubMed
Abstract available
Effectiveness of Adjuvant Capecitabine in Triple-Negative Breast Cancer Patients
With Residual Disease After Neoadjuvant Treatment: A Real-World Evidence Study in
Korea.
Clin Breast Cancer. 2025 Jan 13:S1526-8209(24)00369.
PubMed
Abstract available
The Added Value of Physical Examination for Breast Cancer Recurrence Detection in
Women: A Systematic Review.
Clin Breast Cancer. 2025 Jan 11:S1526-8209(24)00365.
PubMed
Abstract available
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant
Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined
Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials.
Clin Breast Cancer. 2024 Dec 31:S1526-8209(24)00371.
PubMed
Abstract available
A phase II study of abemaciclib for patients with retinoblastoma-positive,
triple-negative metastatic breast cancer.
Clin Cancer Res. 2025 Feb 5. doi: 10.1158/1078-0432.CCR-24-2647.
PubMed
Abstract available
Endothelial cell pY397-FAK expression predicts risk of breast cancer recurrences
after radiotherapy in SweBCG91-RT cohort.
Clin Cancer Res. 2025 Feb 5. doi: 10.1158/1078-0432.CCR-24-2939.
PubMed
Abstract available
RORing CAR T Cells in Solid and Hematologic Cancers: Same but Different.
Clin Cancer Res. 2025;31:437-438.
PubMed
Abstract available
Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and
Epithelial Malignancies.
Clin Cancer Res. 2025;31:503-514.
PubMed
Abstract available
Predicting axillary residual disease after neoadjuvant therapy in breast cancer
using baseline MRI and ultrasound.
Eur Radiol. 2025 Feb 8. doi: 10.1007/s00330-025-11408.
PubMed
Abstract available
Deep learning-based breast cancer diagnosis in breast MRI: systematic review and
meta-analysis.
Eur Radiol. 2025 Feb 5. doi: 10.1007/s00330-025-11406.
PubMed
Abstract available
Current status of breast cancer screening in transgender and gender-diverse
populations.
Eur Radiol. 2025 Jan 31. doi: 10.1007/s00330-025-11355.
PubMed
MicroRNAs as behind-the-scenes molecules in breast cancer metastasis and their
therapeutic role through novel microRNA-based delivery strategies.
Gene. 2025;944:149272.
PubMed
Abstract available
Genetic variants and breast carcinoma susceptibility: Unveiling the role of MTHFR
(rs1801131, rs1801133) and TP53 (rs1042522).
Gene. 2025;942:149259.
PubMed
Abstract available
Controversies regarding encapsulated papillary carcinoma of the breast: an
approach to evaluation and categorisation.
Histopathology. 2025;86:497-513.
PubMed
Abstract available
Evaluation of breast-specific marker expression in metastatic breast cancers:
Correlation with subtype switch.
Histopathology. 2025;86:536-546.
PubMed
Abstract available
The prevalence and clinical significance of residual occult breast cancer after
neoadjuvant chemotherapy: reassessing surgical pathology in cases initially
described as pathological complete response.
Histopathology. 2025 Feb 4. doi: 10.1111/his.15417.
PubMed
Abstract available
ABLATIVE Radiation Therapy for Breast Cancer: The Time Has Come for Innovation.
Int J Radiat Oncol Biol Phys. 2025;121:623-625.
PubMed
Long Noncoding VIM-AS1: Biomarker of Breast Fibrosis Susceptibility After
Radiation Therapy and Promoter of Transforming Growth Factor Beta1-Driven
Fibrosis.
Int J Radiat Oncol Biol Phys. 2025;121:783-797.
PubMed
Abstract available
Preoperative Magnetic Resonance Guided Single-Dose Partial Breast Irradiation:
5-Year Results of the Prospective Single-Arm ABLATIVE Trial.
Int J Radiat Oncol Biol Phys. 2025;121:613-622.
PubMed
Abstract available
Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in
Homologous Recombination Deficient Tumors.
Int J Radiat Oncol Biol Phys. 2025;121:768-779.
PubMed
Abstract available
Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy-Naive Women With
Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the
Phase III FALCON Trial.
J Clin Oncol. 2025 Feb 7:JCO2500116. doi: 10.1200/JCO-25-00116.
PubMed
Annual versus less frequent mammographic surveillance in people with breast
cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised,
phase 3, non-inferiority trial.
Lancet. 2025;405:396-407.
PubMed
Abstract available
Rethinking surveillance after breast cancer.
Lancet. 2025;405:356-358.
PubMed
Aspartate signalling drives lung metastasis via alternative translation.
Nature. 2025;638:244-250.
PubMed
Abstract available
Prevalence, clinicopathologic features and long-term overall survival of early
breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib.
NPJ Breast Cancer. 2025;11:10.
PubMed
Abstract available
Accessible model predicts response in hormone receptor positive HER2 negative
breast cancer receiving neoadjuvant chemotherapy.
NPJ Breast Cancer. 2025;11:11.
PubMed
Abstract available
LINC00882, transcriptionally activated by CEBP-beta and post-transcriptionally
stabilized by METTL14-mediated m(6)A modification, exerts tumorigenesis by
promoting PABPC1-mediated stabilization of ELK3 mRNA.
Oncogene. 2025;44:363-377.
PubMed
Abstract available
CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer
chemoresistance.
Oncogene. 2025 Jan 31. doi: 10.1038/s41388-025-03284.
PubMed
Abstract available
Correction: BRD4-specific PROTAC inhibits basal-like breast cancer partially
through downregulating KLF5 expression.
Oncogene. 2025 Feb 3. doi: 10.1038/s41388-024-03250.
PubMed
Long-term survival of node-positive breast cancer with complete nodal response to
neoadjuvant chemotherapy treated with sentinel lymph node biopsy alone: A
meta-analysis.
Oncology. 2025 Feb 3:1-23. doi: 10.1159/000543662.
PubMed
Abstract available
Treatment and reasons for choosing treatment in breast cancer patients who
underwent next-generation sequencing test.
Oncology. 2025 Feb 4:1-21. doi: 10.1159/000543732.
PubMed
Abstract available
Efficacy of acupuncture in treating chemotherapy-related cognitive impairment in
breast cancer patients: A systematic review and meta-analysis protocol.
PLoS One. 2025;20:e0318984.
PubMed
Abstract available
Machine learning identifies the association between second primary malignancies
and postoperative radiotherapy in young-onset breast cancer patients.
PLoS One. 2025;20:e0316722.
PubMed
Abstract available
Performance of Two Deep Learning-based AI Models for Breast Cancer Detection and
Localization on Screening Mammograms from BreastScreen Norway.
Radiol Artif Intell. 2025 Feb 5:e240039. doi: 10.1148/ryai.240039.
PubMed
Abstract available
Using AI to Select Women with Intermediate Breast Cancer Risk for Breast
Screening with MRI.
Radiology. 2025;314:e233067.
PubMed
Abstract available
Machine learning model for predicting DIBH non-eligibility in left-sided breast
cancer radiotherapy: Development, validation and clinical impact analysis.
Radiother Oncol. 2025;205:110764.
PubMed
Abstract available
Radiation therapy and immigration status in women with breast cancer.
Radiother Oncol. 2025 Jan 31:110774. doi: 10.1016/j.radonc.2025.110774.
PubMed
Abstract available
Thank you for your interest in scientific medicine.